Clinical Trial Update: Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of sorafenib and gemcitabine in advanced hepatocellular carcinoma; the status of the study is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Gemzar (gemcitabine)
• Nexavar (Sorafenib)

Snippet

Sponsor: Combined Military Hospital, Pakistan | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN